Royalty Pharma (RPRX) Cash & Equivalents Growth (1y) (2020 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | 28.50% |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | -26.48% |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | 52.35% |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | -60.49% |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | 85.97% |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | -1.44% |
| 10 | Metalla Royalty & Streaming | 942.93 Mn | 931.86 Mn | 4.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.50% |
| Mar 31, 2026 | -46.09% |
| Dec 31, 2025 | -33.40% |
| Sep 30, 2025 | -1.17% |
| Jun 30, 2025 | -64.19% |
| Mar 31, 2025 | 29.03% |
| Dec 31, 2024 | 94.76% |
| Sep 30, 2024 | 1.45% |
| Jun 30, 2024 | -18.80% |
| Mar 31, 2024 | -57.33% |
| Dec 31, 2023 | -72.12% |
| Sep 30, 2023 | -5.56% |
| Jun 30, 2023 | 3.09% |
| Mar 31, 2023 | 10.28% |
| Dec 31, 2022 | 11.01% |
| Sep 30, 2022 | -44.93% |
| Jun 30, 2022 | 84.55% |
| Mar 31, 2022 | 152.75% |
| Dec 31, 2021 | 52.78% |
| Sep 30, 2021 | 15.97% |